BMJ  2006;332 (13 May), doi:10.1136/bmj.332.7550.0

Statins show greater benefit for diabetic patients

Lipid lowering drugs significantly reduce cardiovascular risk, but they may be especially effective in patients with diabetes. Costa and colleagues (p 1115) carried out a meta-analysis of 12 randomised controlled trials with follow-ups of at least three years that evaluated lipid lowering drug treatment in patients with or without type 2 diabetes.

Credit: SPL

 

Risk reductions in primary and secondary prevention were similar in both groups, but, after adjustment for baseline risk, the diabetic patients showed greater benefit.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Can sutures get wet? Prospective randomised controlled trial of wound management in general practice

Clare Heal, Petra Buettner, Beverly Raasch, Sheldon Browning, David Graham, Rachel Bidgood, Margaret Campbell, and Robert Cruikshank
BMJ 2006 332: 1053-1056. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Diabetes and past myocardial infarction are not equivalent risk factors for coronary events

John I Levitt
bmj.com, 30 May 2006 [Full text]